| 1 |
[GO] |
2023―Aug―10 |
Stabilization of RNA G-quadruplexes in the SARS-CoV-2 genome inhibits viral infection via translational suppression |
Maria Razzaq, Ji Ho Han, Subramaniyam Ravichandran, Jaehyun Kim, Joon-Yong Bae, Man-Seong Park, Shrute Kannappan, Woo-Chang Chung, Jin-Hyun Ahn, Moon Jung Song, Kyeong Kyu Kim |
| 2 |
[GO] |
2022―Nov―28 |
Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms |
Faezeh Almasi, Wen Dang, Fatemeh Mohammadipanah, Ning Li |
| 3 |
[GO] |
2021―Jul―24 |
Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis |
Sujata Purja, Hocheol Shin, Ji-Yun Lee, EunYoung Kim |
| 4 |
[GO] |
2021―May―28 |
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development |
Joowon Yim, Hee Hyun Lim, Youngjoo Kwon |
| 5 |
[GO] |
2021―Jan―04 |
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective |
Choongho Lee, Won Jun Choi |
| 6 |
[GO] |
2021―Jan―04 |
Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm |
Chang Hoon Lee |
| 7 |
[GO] |
2020―Aug―01 |
Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19 |
Li Zou, Lijun Dai, Xingyu Zhang, Zhaohui Zhang, Zhentao Zhang |
